Brickell Biotech Company
Brickell Biotech is a pharmaceutical company that specializes in creating prescription drugs for skin diseases. Their main focus is on developing a drug called sofpironium bromide, which is used to treat hyperhidrosis.
Acquisitions Number:
1
Founded Date:
2009
Last Funding Type:
Post-IPO Equity
Headquarters:
Miami, Florida, United States
Investors Number:
3.0
Technology:
Biotechnology, Health Care, Therapeutics
Employee Number:
11-50
Industry:
End-to-End Drug Development
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-07-19
Funding Status:
IPO
Total Funding:
33464587.0